Did You Know?

Editor’s Picks

Latest News

Clearside Biomedical Announces Completion of Dosing in Cohort 2 of Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMD Patients

ALPHARETTA, Ga., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments...

Izotropic Signs Agreement with Johns Hopkins University School of Medicine to Develop Deep Machine Learning Algorithms for IzoView Breast CT

Vancouver, British Columbia--(Newsfile Corp. - September 21, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing...

Community Behavioural Health Association of Maryland Transforming Mental Health Care with Implementation of Greenspace Health Measurement-Based Care Solution

Initiative gives clinicians and clients greater insight into care to provide a significant improvement in behavioural healthcare outcomes. CATONSVILLE, Md.--(BUSINESS...

Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies

Mycrodose Therapeutics successfully closes oversubscribed seven-figure financing round.Financing was funded by multiple high profile institutional investors, VCs, and Psychedelic Funds,...

error: Content is protected !!